Miscellaneous ocular agents:

Indications for JETREA:

Treatment of symptomatic vitreomacular adhesion.


Give by intravitreal inj. 0.125mg (0.1mL of the diluted soln) once as a single dose to the affected eye.


Not recommended.


For ophthalmic intravitreal inj only. Monitor for elevation in intraocular pressure immediately after inj. Monitor for decreased vision. Repeated administration in the same eye: not recommended. Treatment in the other eye is not recommended within 7 days of the initial inj. Pregnancy (Cat.C). Nursing mothers.

Pharmacologic Class:

Proteolytic enzyme.

Adverse Reactions:

Vitreous floaters, conjunctival hemorrhage, eye pain, photopsia, blurred vision, macular hole, reduced visual acuity, visual impairment, retinal edema; intraocular inflammation/infection/hemorrhage, increased intraocular pressure, yellowish vision.

Generic Availability:


How Supplied:

Single-use vial (0.2mL)—1

Pricing for JETREA

0.2ml of 2.5mg/ml vial (Qty: 1)
Appx. price $4039